
Biopharma is on edge about NIH funding cuts and what the future holds for research
Proposed funding cuts to the National Institutes of Health might not make a huge splash in biopharma right away, but industry leaders have expressed concern over potential ripples left in their wake. As they stand currently, cuts by the Trump …